arrow
K

Kristin Kaasen Jørgensen

Oslo University Hospital
H指数:24
被引数:2,528

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantation

地理无关的黏膜微生物群改变在原发性硬化性胆管炎患者中肝移植后持续存在

2025-12-220
OAAI
Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC

永久性回肠造口术的结肠切除术与PSC患者的无移植生存率的改善相关。

2025-12-220
OAAI
Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease

炎症性肠病期间SARS-CoV-2混合免疫力不足

2025-02-010
OAAI
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
2025-01-010
PRE
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
2024-10-011
OAAI
NEUTRALISING ANTIBODY RESPONSES TO BIVALENT SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ONTNF INHIBITORS: A PROSPECTIVE COHORT STUDY

对接受抗TNF抑制剂治疗的患者接种双价SARS-CoV-2疫苗及混合免疫后的中和抗体反应:一项前瞻性队列研究

2024-06-010
PRE
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study
2024-02-222
OAAI
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
2023-06-0617
OAAI
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
2023-02-266
OA
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
2023-01-0121
OAAI
Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis
2022-11-188
OAAI
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study
2022-10-0513
OAAI
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
2022-06-2945
OA
Impact on follow-up strategies in patients with primary sclerosing cholangitis
2022-05-1624
OAAI